Dr. Quazi T. H. Shubhra earned his PhD in Nanotechnology from the University of Pannonia, Hungary, as a Marie Curie fellow in October 2014, and completed postdoctoral research in Japan and China, where he expanded his expertise in innovative drug delivery systems for cancer therapy. He holds a BSc and MSc in Applied Chemistry from the University of Dhaka, Bangladesh.

Currently, Dr. Shubhra is a Distinguished Professor at Renmin Hospital of Wuhan University, China, and an Assistant Professor at the University of Silesia, Poland. He has published over 50 SCI articles in top-tier journals including Nature Reviews Chemistry, Nature Chemistry, Annals of Oncology, Signal Transduction and Targeted Therapy, and Cell Metabolism, focuses on the development of cutting-edge nanotechnology applications in drug delivery.

Dr. Shubhra’s contributions to science are recognized globally through prestigious accolades such as the Marie Curie PhD and JSPS postdoc fellowships, along with other awards. He has actively participated in high-profile scientific forums, including the 65th Lindau Nobel Laureate Meeting in Germany and the 8th HOPE Meeting in Japan.

As an active contributor to the scientific community, Dr. Shubhra serves on the editorial boards of several renowned journals and has been a reviewer for numerous high-impact publications. His dedication to advancing the field of nanomedicine is reflected in his ongoing efforts to develop cutting-edge therapeutic strategies and foster the next generation of scientific leaders.